ID · State regulatory reference
Idaho.
Permissive
Idaho is one of the least-regulated states for both telehealth and compounding, on a cited statutory basis. The Idaho Virtual Care Access Act (Idaho Code §§ 54-5701–54-5714) and prescribing statute § 54-1733 let a prescriber establish a patient relationship and prescribe through virtual care with no prior in-person visit, subject only to the Idaho community standard of care and a bar on prescribing 'based solely on a static online questionnaire.' The Board of Pharmacy's compounding rule (IDAPA 24.36.01.700) adopts USP 795/797 with no GLP-1-specific overlay. The only Idaho-specific GLP-1 items are consumer counterfeit/fraud advisories, not restrictions on legitimate 503A compounding.
Last reviewed · 2026-05-25 · verified entry
Agencies
TPC notes
Telehealth
Under Idaho Code §§ 54-5705, 54-5707 and 54-1733, an initial visit and prescribing may occur via synchronous virtual care with no in-person requirement if the community standard of care is met; a prescription based solely on a static online questionnaire is not a legitimate medical purpose.
Compounding
IDAPA 24.36.01.700 incorporates USP 795/797 with no GLP-1/semaglutide-specific limits or extra state overlay, reflecting Idaho's broad standard-of-care deregulation; Idaho-specific GLP-1 notices are fraud/counterfeit and clinic-dispensing advisories, not compounding restrictions.
Sources